Company Profile

Pharmatech Oncology Inc (AKA: Pharmatech)
Profile last edited on: 5/2/19      CAGE: 58LM1      UEI:

Business Identifier: Oncology cinical trial support and services
Year Founded
1987
First Award
2010
Latest Award
2013
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

789 Sherman Street Suite 310
Denver, CO 80203
   (720) 917-8400
   info@pharmatech.com
   www.pharmatech.com
Location: Single
Congr. District: 01
County: Denver

Public Profile

Formerly doing business as Pharmatech Oncology, Inc., the renamed PharmaTech is a Site Management Organization (SMO) specializing in creating efficiencies in the clinical trial process. Through an organized network of clinics, the Company is focused on advancing the development of products for a broad range of pharmaceutical and biotechnology companies, and on promoting the inclusion of clinical trials in the spectrum of patient treatment options. Providing service to pharmaceutical and biotechnology clients for the development and management of clinical research trials, the company focuses on oncology clinical trials. Pharmatech's contract research organization services include protocol design, case report form design, data management, project feasibility assessments, statistical analysis, final reporting, and publication. The company’s site management organization services include site identification, selection, and management; management of regulatory documents; grant management; centralized contracting; and research advisory and investigator meetings

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
100-149
Revenue Range
10M-15M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2013 2 NIH $1,769,329
Project Title: A Patient-Centered Approach To Enrolling Rare Cancer Patients In Clinical Trials

Key People / Management

  Rob Bohacs -- CEO

  Eric Lynam -- Executive Director

  Matthew B Wiener -- Founder and CSO